231 related articles for article (PubMed ID: 36500562)
1. Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.
Bao L; Ye J; Liu N; Shao Y; Li W; Fan X; Zhao D; Wang H; Chen X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500562
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway.
Liu N; Fan X; Shao Y; Chen S; Wang T; Yao T; Chen X
J Transl Med; 2024 May; 22(1):457. PubMed ID: 38745204
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.
Yang G; Lyu L; Wang X; Bao L; Lyu B; Lin Z
Pulm Pharmacol Ther; 2019 Jun; 56():69-74. PubMed ID: 30930172
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD).
O'Dwyer DN; Armstrong ME; Cooke G; Dodd JD; Veale DJ; Donnelly SC
Eur J Intern Med; 2013 Oct; 24(7):597-603. PubMed ID: 23916467
[TBL] [Abstract][Full Text] [Related]
5. Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
Jeong E; Hong H; Lee YA; Kim KS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473928
[TBL] [Abstract][Full Text] [Related]
6. Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway.
Ba X; Wang H; Huang Y; Yan J; Han L; Lin W; Shen P; Huang Y; Yang S; Qin K; Tu S; Chen Z
J Ethnopharmacol; 2023 Jun; 309():116274. PubMed ID: 36841380
[TBL] [Abstract][Full Text] [Related]
7. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
Juge PA; Crestani B; Dieudé P
Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
[TBL] [Abstract][Full Text] [Related]
9. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies.
Diesler R; Cottin V
Expert Rev Respir Med; 2022 May; 16(5):541-553. PubMed ID: 35695895
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial lung disease in rheumatoid arthritis].
Froidevaux-Janin S; Dudler J; Nicod LP; Lazor R
Rev Med Suisse; 2011 Nov; 7(318):2272-7. PubMed ID: 22400361
[TBL] [Abstract][Full Text] [Related]
12. Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China.
Liu L; Fang C; Sun B; Bao R; Zhang H
Int J Rheum Dis; 2022 Jul; 25(7):795-802. PubMed ID: 35633522
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
Chen N; Diao CY; Gao J; Zhao DB
Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y
Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858
[TBL] [Abstract][Full Text] [Related]
15. Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.
Wu X; Jeong Y; Poli de Frías S; Easthausen I; Hoffman K; Oromendia C; Taheri S; Esposito AJ; Quesada Arias L; Ayaub EA; Maurer R; Gill RR; Hatabu H; Nishino M; Frits ML; Iannaccone CK; Weinblatt ME; Shadick NA; Dellaripa PF; Choi AMK; Kim EY; Rosas IO; Martinez FJ; Doyle TJ
Thorax; 2022 Oct; 77(10):1041-1044. PubMed ID: 35907639
[TBL] [Abstract][Full Text] [Related]
16. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.
Brito Y; Glassberg MK; Ascherman DP
Curr Rheumatol Rep; 2017 Nov; 19(12):79. PubMed ID: 29119259
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in rheumatoid arthritis.
Ascherman DP
Curr Rheumatol Rep; 2010 Oct; 12(5):363-9. PubMed ID: 20628839
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3).
Wu C; Lin H; Zhang X
Int Immunopharmacol; 2019 Sep; 74():105700. PubMed ID: 31228816
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis.
Lai NL; Jia W; Wang X; Luo J; Liu GY; Gao C; Li XF; Xie JF
Can Respir J; 2019; 2019():7262065. PubMed ID: 31885749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
